Home ➤ Life Science ➤ Biotechnology ➤ Molecular Diagnostics Market
Molecular Diagnostics Market
Published date: Aug 2025 • Formats:
Request Sample Schedule a Call

Molecular Diagnostic Market By Product Type (Instruments & Systems, Reagents & Kits, Software & Others), By Technology (Polymerase chain reaction (PCR), Transcription Mediated Amplification (TMA), Sequencing, Mass Spectrometry, Isothermal Nucleic Acid Amplification Technology (INAAT), In Situ Hybridization (ISH), Chips & Microarrays, Other Technologies), By Application (Infectious Disease, Oncology, Pharmacogenomics, Genetic Testing, Neurological Disease, Microbiology, Cardiovascular Disease, Others), By Test Location (Point of Care, Central Laboratories, Self-test or OTC), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: Aug 2025
  • Report ID: 16242
  • Number of Pages: 302
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Molecular Diagnostic Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Molecular Diagnostic Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Molecular Diagnostic Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Molecular Diagnostic Market Attractiveness Analysis, By Product Type
        • 3.3.1. Reagents & Kits
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Instruments & Systems
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Software & Others
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
      • 3.4. Global Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 3.5. Global Molecular Diagnostic Market Attractiveness Analysis, By Technology
        • 3.5.1. Polymerase Chain Reaction (PCR)
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
            • 3.5.1.2.1. Multiplex PCR
            • 3.5.1.2.2. Others
        • 3.5.2. Transcription Mediated Amplification (TMA)
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Sequencing
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Mass Spectrometry
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
        • 3.5.6. In Situ Hybridization (ISH)
          • 3.5.6.1. Insights
          • 3.5.6.2. Key Takeaways
        • 3.5.7. Chips & Microarrays
          • 3.5.7.1. Insights
          • 3.5.7.2. Key Takeaways
        • 3.5.8. Other Technologies
          • 3.5.8.1. Insights
          • 3.5.8.2. Key Takeaways
      • 3.6. Global Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.7. Global Molecular Diagnostic Market Attractiveness Analysis, By Application
        • 3.7.1. Infectious Disease
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Oncology
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
            • 3.7.2.2.1. Prostate Cancer
            • 3.7.2.2.2. Lung Cancer
            • 3.7.2.2.3. Colorectal Cancer
            • 3.7.2.2.4. Breast Cancer
            • 3.7.2.2.5. Others
        • 3.7.3. Pharmacogenomics
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
            • 3.7.3.2.1. Tuberculosis & Drug-resistant TBA
            • 3.7.3.2.2. Meningitis
            • 3.7.3.2.3. Infectious Diseases
            • 3.7.3.2.4. HIV
            • 3.7.3.2.5. Hepatitis C
            • 3.7.3.2.6. Candida
            • 3.7.3.2.7. Hepatitis B
            • 3.7.3.2.8. Others
        • 3.7.4. Genetic Testing
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
            • 3.7.4.2.1. Newborn Screening
            • 3.7.4.2.2. Predictive & Presymptomatic Testing
            • 3.7.4.2.3. Other Genetic Testing
        • 3.7.5. Neurological Disease
          • 3.7.5.1. Insights
          • 3.7.5.2. Key Takeaways
        • 3.7.6. Microbiology
          • 3.7.6.1. Insights
          • 3.7.6.2. Key Takeaways
        • 3.7.7. Cardiovascular Disease
          • 3.7.7.1. Insights
          • 3.7.7.2. Key Takeaways
        • 3.7.8. Others
          • 3.7.8.1. Insights
          • 3.7.8.2. Key Takeaways
      • 3.8. Global Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 3.9. Global Molecular Diagnostic Market Attractiveness Analysis, By Test Location
        • 3.9.1. Central Laboratories
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Point of Care
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Self-Test or OTC
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
    • 4. Global Molecular Diagnostic Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Molecular Diagnostic Market Attractiveness Analysis, By Region
    • 5. North America Molecular Diagnostic Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • 5.4. North America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 5.5. North America Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • 5.6. North America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.7. North America Molecular Diagnostic Market Attractiveness Analysis, By Application
      • 5.8. North America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 5.9. North America Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • 5.10. North America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Molecular Diagnostic Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Molecular Diagnostic Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 6.5. Europe Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • 6.6. Europe Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.7. Europe Molecular Diagnostic Market Attractiveness Analysis, By Application
      • 6.8. Europe Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 6.9. Europe Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • 6.10. Europe Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Molecular Diagnostic Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Molecular Diagnostic Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 7.5. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • 7.6. Asia Pacific Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.7. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Application
      • 7.8. Asia Pacific Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 7.9. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • 7.10. Asia Pacific Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Molecular Diagnostic Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 8.5. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • 8.6. Latin America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.7. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Application
      • 8.8. Latin America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 8.9. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • 8.10. Latin America Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Molecular Diagnostic Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
      • 9.5. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • 9.6. Middle East & Africa Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.7. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Application
      • 9.8. Middle East & Africa Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Test Location, 2020-2034
      • 9.9. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • 9.10. Middle East & Africa Molecular Diagnostic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Sysmex Corporation
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Siemens Healthineers AG
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. QIAGEN
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Illumina, Inc
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Hologic Inc. (Gen Probe)
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. F. Hoffmann-La Roche, Ltd
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Danaher
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. Bio-Rad Laboratories, Inc
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. bioMérieux SA
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. BD
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. Agilent Technologies, Inc
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Abbott
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020-2034
      • Table 3. Global Molecular Diagnostic Market Value (US$ Mn), By Application, 2020-2034
      • Table 4. Global Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020-2034
      • Table 5. Global Molecular Diagnostic Market Value (US$ Mn), By Region, 2020-2034
      • Table 6. North America Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 7. North America Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 8. North America Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 9. North America Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 10. North America Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 11. North America Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 12. North America Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 13. North America Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 14. North America Molecular Diagnostic Market Value (US$ Mn), By Country, 2020–2034
      • Table 15. The US Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 16. The US Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 17. The US Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 18. The US Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 19. The US Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 20. The US Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 21. The US Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 22. The US Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 23. Canada Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 24. Canada Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 25. Canada Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 26. Canada Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 27. Canada Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 28. Canada Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 29. Canada Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 30. Canada Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 31. Europe Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 32. Europe Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 33. Europe Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 34. Europe Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 35. Europe Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 36. Europe Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 37. Europe Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 38. Europe Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 39. Europe Molecular Diagnostic Market Value (US$ Mn), By Country, 2020–2034
      • Table 40. Germany Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 41. Germany Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 42. Germany Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 43. Germany Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 44. Germany Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 45. Germany Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 46. Germany Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 47. Germany Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 48. France Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 49. France Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 50. France Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 51. France Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 52. France Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 53. France Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 54. France Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 55. France Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 56. UK Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 57. UK Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 58. UK Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 59. UK Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 60. UK Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 61. UK Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 62. UK Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 63. UK Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 64. Spain Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 65. Spain Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 66. Spain Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 67. Spain Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 68. Spain Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 69. Spain Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 70. Spain Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 71. Spain Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 72. Italy Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 73. Italy Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 74. Italy Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 75. Italy Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 76. Italy Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 77. Italy Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 78. Italy Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 79. Italy Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 80. Russia Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 81. Russia Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 82. Russia Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 83. Russia Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 84. Russia Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 85. Russia Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 86. Russia Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 87. Russia Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 88. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 89. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 90. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 91. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 92. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 93. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 94. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 95. Netherlands Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 96. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 97. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 98. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 99. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 100. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 101. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 102. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 103. Rest of Europe Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 104. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 105. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 106. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 107. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 108. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 109. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 110. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 111. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 112. Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Country, 2020–2034
      • Table 113. China Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 114. China Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 115. China Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 116. China Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 117. China Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 118. China Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 119. China Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 120. China Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 121. Japan Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 122. Japan Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 123. Japan Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 124. Japan Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 125. Japan Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 126. Japan Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 127. Japan Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 128. Japan Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 129. South Korea Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 130. South Korea Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 131. South Korea Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 132. South Korea Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 133. South Korea Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 134. South Korea Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 135. South Korea Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 136. South Korea Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 137. India Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 138. India Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 139. India Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 140. India Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 141. India Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 142. India Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 143. India Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 144. India Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 145. Australia Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 146. Australia Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 147. Australia Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 148. Australia Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 149. Australia Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 150. Australia Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 151. Australia Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 152. Australia Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 153. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 154. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 155. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 156. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 157. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 158. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 159. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 160. New Zealand Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 161. Singapore Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 162. Singapore Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 163. Singapore Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 164. Singapore Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 165. Singapore Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 166. Singapore Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 167. Singapore Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 168. Singapore Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 169. Thailand Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 170. Thailand Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 171. Thailand Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 172. Thailand Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 173. Thailand Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 174. Thailand Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 175. Thailand Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 176. Thailand Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 177. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 178. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 179. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 180. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 181. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 182. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 183. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 184. Vietnam Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 185. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 186. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 187. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 188. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 189. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 190. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 191. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 192. Rest of Asia Pacific Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 193. Latin America Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 194. Latin America Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 195. Latin America Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 196. Latin America Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 197. Latin America Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 198. Latin America Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 199. Latin America Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 200. Latin America Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 201. Latin America Molecular Diagnostic Market Value (US$ Mn), By Country, 2020–2034
      • Table 202. Brazil Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 203. Brazil Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 204. Brazil Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 205. Brazil Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 206. Brazil Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 207. Brazil Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 208. Brazil Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 209. Brazil Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 210. Mexico Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 211. Mexico Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 212. Mexico Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 213. Mexico Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 214. Mexico Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 215. Mexico Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 216. Mexico Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 217. Mexico Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 218. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 219. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 220. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 221. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 222. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 223. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 224. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 225. Rest of Latin America Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 226. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 227. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 228. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 229. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 230. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 231. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 232. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 233. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 234. Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Country, 2020–2034
      • Table 235. South Africa Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 236. South Africa Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 237. South Africa Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 238. South Africa Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 239. South Africa Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 240. South Africa Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 241. South Africa Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 242. South Africa Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 243. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 244. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 245. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 246. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 247. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 248. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 249. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 250. Saudi Arabia Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 251. UAE Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 252. UAE Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 253. UAE Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 254. UAE Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 255. UAE Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 256. UAE Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 257. UAE Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 258. UAE Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
      • Table 259. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Product Type, 2020–2034
      • Table 260. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Technology, 2020–2034
      • Table 261. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Polymerase Chain Reaction (PCR), 2020–2034
      • Table 262. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Application, 2020–2034
      • Table 263. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Oncology, 2020–2034
      • Table 264. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Pharmacogenomics, 2020–2034
      • Table 265. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Genetic Testing, 2020–2034
      • Table 266. Rest of Middle East & Africa Molecular Diagnostic Market Value (US$ Mn), By Test Location, 2020–2034
    • List of Figures
      • Figure 1. Global Molecular Diagnostic Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Molecular Diagnostic Market
      • Figure 5. Global Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 8. Global Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 9. Global Molecular Diagnostic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 10. Global Molecular Diagnostic Market Attractiveness Analysis, By Application
      • Figure 11. Global Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 12. Global Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 13. Global Molecular Diagnostic Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Molecular Diagnostic Market Attractiveness Analysis, By Region
      • Figure 15. North America Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 16. North America Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 17. North America Molecular Diagnostic Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 18. North America Molecular Diagnostic Market (US$ Mn), by Instruments & Systems, 2020-2034
      • Figure 19. North America Molecular Diagnostic Market (US$ Mn), by Software & Others, 2020-2034
      • Figure 20. North America Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 21. North America Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 22. North America Molecular Diagnostic Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 23. North America Molecular Diagnostic Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 24. North America Molecular Diagnostic Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 25. North America Molecular Diagnostic Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 26. North America Molecular Diagnostic Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 27. North America Molecular Diagnostic Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 28. North America Molecular Diagnostic Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 29. North America Molecular Diagnostic Market (US$ Mn), by Other Technologies, 2020-2034
      • Figure 30. North America Molecular Diagnostic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 31. North America Molecular Diagnostic Market Attractiveness Analysis, By Application
      • Figure 32. North America Molecular Diagnostic Market (US$ Mn), by Infectious Disease, 2020-2034
      • Figure 33. North America Molecular Diagnostic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 34. North America Molecular Diagnostic Market (US$ Mn), by Pharmacogenomics, 2020-2034
      • Figure 35. North America Molecular Diagnostic Market (US$ Mn), by Genetic Testing, 2020-2034
      • Figure 36. North America Molecular Diagnostic Market (US$ Mn), by Neurological Disease, 2020-2034
      • Figure 37. North America Molecular Diagnostic Market (US$ Mn), by Microbiology, 2020-2034
      • Figure 38. North America Molecular Diagnostic Market (US$ Mn), by Cardiovascular Disease, 2020-2034
      • Figure 39. North America Molecular Diagnostic Market (US$ Mn), by Others, 2020-2034
      • Figure 40. North America Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 41. North America Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 42. North America Molecular Diagnostic Market (US$ Mn), by Central Laboratories, 2020-2034
      • Figure 43. North America Molecular Diagnostic Market (US$ Mn), by Point of Care, 2020-2034
      • Figure 44. North America Molecular Diagnostic Market (US$ Mn), by Self-Test or OTC, 2020-2034
      • Figure 45. North America Molecular Diagnostic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 46. North America Molecular Diagnostic Market Attractiveness Analysis, By Country
      • Figure 47. Europe Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 48. Europe Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 49. Europe Molecular Diagnostic Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 50. Europe Molecular Diagnostic Market (US$ Mn), by Instruments & Systems, 2020-2034
      • Figure 51. Europe Molecular Diagnostic Market (US$ Mn), by Software & Others, 2020-2034
      • Figure 52. Europe Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 53. Europe Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 54. Europe Molecular Diagnostic Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 55. Europe Molecular Diagnostic Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 56. Europe Molecular Diagnostic Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 57. Europe Molecular Diagnostic Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 58. Europe Molecular Diagnostic Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 59. Europe Molecular Diagnostic Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 60. Europe Molecular Diagnostic Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 61. Europe Molecular Diagnostic Market (US$ Mn), by Other Technologies, 2020-2034
      • Figure 62. Europe Molecular Diagnostic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 63. Europe Molecular Diagnostic Market Attractiveness Analysis, By Application
      • Figure 64. Europe Molecular Diagnostic Market (US$ Mn), by Infectious Disease, 2020-2034
      • Figure 65. Europe Molecular Diagnostic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 66. Europe Molecular Diagnostic Market (US$ Mn), by Pharmacogenomics, 2020-2034
      • Figure 67. Europe Molecular Diagnostic Market (US$ Mn), by Genetic Testing, 2020-2034
      • Figure 68. Europe Molecular Diagnostic Market (US$ Mn), by Neurological Disease, 2020-2034
      • Figure 69. Europe Molecular Diagnostic Market (US$ Mn), by Microbiology, 2020-2034
      • Figure 70. Europe Molecular Diagnostic Market (US$ Mn), by Cardiovascular Disease, 2020-2034
      • Figure 71. Europe Molecular Diagnostic Market (US$ Mn), by Others, 2020-2034
      • Figure 72. Europe Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 73. Europe Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 74. Europe Molecular Diagnostic Market (US$ Mn), by Central Laboratories, 2020-2034
      • Figure 75. Europe Molecular Diagnostic Market (US$ Mn), by Point of Care, 2020-2034
      • Figure 76. Europe Molecular Diagnostic Market (US$ Mn), by Self-Test or OTC, 2020-2034
      • Figure 77. Europe Molecular Diagnostic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 78. Europe Molecular Diagnostic Market Attractiveness Analysis, By Country
      • Figure 79. Asia Pacific Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 80. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 81. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 82. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Instruments & Systems, 2020-2034
      • Figure 83. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Software & Others, 2020-2034
      • Figure 84. Asia Pacific Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 85. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 86. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 87. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 88. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 89. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 90. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 91. Asia Pacific Molecular Diagnostic Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 92. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 93. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Other Technologies, 2020-2034
      • Figure 94. Asia Pacific Molecular Diagnostic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 95. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Application
      • Figure 96. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Infectious Disease, 2020-2034
      • Figure 97. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 98. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Pharmacogenomics, 2020-2034
      • Figure 99. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Genetic Testing, 2020-2034
      • Figure 100. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Neurological Disease, 2020-2034
      • Figure 101. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Microbiology, 2020-2034
      • Figure 102. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Cardiovascular Disease, 2020-2034
      • Figure 103. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Others, 2020-2034
      • Figure 104. Asia Pacific Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 105. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 106. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Central Laboratories, 2020-2034
      • Figure 107. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Point of Care, 2020-2034
      • Figure 108. Asia Pacific Molecular Diagnostic Market (US$ Mn), by Self-Test or OTC, 2020-2034
      • Figure 109. Asia Pacific Molecular Diagnostic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 110. Asia Pacific Molecular Diagnostic Market Attractiveness Analysis, By Country
      • Figure 111. Latin America Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 112. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 113. Latin America Molecular Diagnostic Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 114. Latin America Molecular Diagnostic Market (US$ Mn), by Instruments & Systems, 2020-2034
      • Figure 115. Latin America Molecular Diagnostic Market (US$ Mn), by Software & Others, 2020-2034
      • Figure 116. Latin America Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 117. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 118. Latin America Molecular Diagnostic Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 119. Latin America Molecular Diagnostic Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 120. Latin America Molecular Diagnostic Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 121. Latin America Molecular Diagnostic Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 122. Latin America Molecular Diagnostic Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 123. Latin America Molecular Diagnostic Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 124. Latin America Molecular Diagnostic Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 125. Latin America Molecular Diagnostic Market (US$ Mn), by Other Technologies, 2020-2034
      • Figure 126. Latin America Molecular Diagnostic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 127. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Application
      • Figure 128. Latin America Molecular Diagnostic Market (US$ Mn), by Infectious Disease, 2020-2034
      • Figure 129. Latin America Molecular Diagnostic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 130. Latin America Molecular Diagnostic Market (US$ Mn), by Pharmacogenomics, 2020-2034
      • Figure 131. Latin America Molecular Diagnostic Market (US$ Mn), by Genetic Testing, 2020-2034
      • Figure 132. Latin America Molecular Diagnostic Market (US$ Mn), by Neurological Disease, 2020-2034
      • Figure 133. Latin America Molecular Diagnostic Market (US$ Mn), by Microbiology, 2020-2034
      • Figure 134. Latin America Molecular Diagnostic Market (US$ Mn), by Cardiovascular Disease, 2020-2034
      • Figure 135. Latin America Molecular Diagnostic Market (US$ Mn), by Others, 2020-2034
      • Figure 136. Latin America Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 137. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 138. Latin America Molecular Diagnostic Market (US$ Mn), by Central Laboratories, 2020-2034
      • Figure 139. Latin America Molecular Diagnostic Market (US$ Mn), by Point of Care, 2020-2034
      • Figure 140. Latin America Molecular Diagnostic Market (US$ Mn), by Self-Test or OTC, 2020-2034
      • Figure 141. Latin America Molecular Diagnostic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 142. Latin America Molecular Diagnostic Market Attractiveness Analysis, By Country
      • Figure 143. Middle East & Africa Molecular Diagnostic Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 144. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Product Type
      • Figure 145. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Reagents & Kits, 2020-2034
      • Figure 146. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Instruments & Systems, 2020-2034
      • Figure 147. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Software & Others, 2020-2034
      • Figure 148. Middle East & Africa Molecular Diagnostic Market Analysis, By Technology, 2020, 2024 and 2034
      • Figure 149. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Technology
      • Figure 150. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Polymerase Chain Reaction (PCR), 2020-2034
      • Figure 151. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Transcription Mediated Amplification (TMA), 2020-2034
      • Figure 152. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Sequencing, 2020-2034
      • Figure 153. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Mass Spectrometry, 2020-2034
      • Figure 154. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Isothermal Nucleic Acid Amplification Technology (INAAT), 2020-2034
      • Figure 155. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by In Situ Hybridization (ISH), 2020-2034
      • Figure 156. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Chips & Microarrays, 2020-2034
      • Figure 157. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Other Technologies, 2020-2034
      • Figure 158. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Application, 2020, 2024 and 2034
      • Figure 159. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Infectious Disease, 2020-2034
      • Figure 160. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 161. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Pharmacogenomics, 2020-2034
      • Figure 162. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Genetic Testing, 2020-2034
      • Figure 163. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Neurological Disease, 2020-2034
      • Figure 164. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Microbiology, 2020-2034
      • Figure 165. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Cardiovascular Disease, 2020-2034
      • Figure 166. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Others, 2020-2034
      • Figure 167. Middle East & Africa Molecular Diagnostic Market Analysis, By Test Location, 2020, 2024 and 2034
      • Figure 168. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Test Location
      • Figure 169. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Central Laboratories, 2020-2034
      • Figure 170. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Point of Care, 2020-2034
      • Figure 171. Middle East & Africa Molecular Diagnostic Market (US$ Mn), by Self-Test or OTC, 2020-2034
      • Figure 172. Middle East & Africa Molecular Diagnostic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 173. Middle East & Africa Molecular Diagnostic Market Attractiveness Analysis, By Country

Related Reports

Our Clients

  • Our Clients
Molecular Diagnostics Market
  • 16242
  • Aug 2025
    • ★★★★★
      ★★★★★
    • (104)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options